- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Henry Schein Inc(HSIC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for HSIC
11/20/2026: HSIC (1-star) is currently NOT-A-BUY. Pass it for now.
Henry Schein Inc is a leading global distributor of healthcare products, specialty medical supplies, and practice management software to office-based dental and medical practitioners. The company's main business strengths lie in its entrenched global distribution network and sticky software solutions that drive steady, recurring demand. Its primary growth opportunity centers on expanding higher-margin specialty products like dental implants and advanced digital workflow tools. Key risks include narrow core distribution margins, intense competition, and macroeconomic sensitivity affecting elective healthcare procedures. The stock suits value and low-risk investors seeking stable exposure to essential healthcare markets, with investors closely monitoring specialty product growth and operating margin trends.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Henry Schein offers steady mid-single-digit growth rather than rapid hyper-growth characteristic of early-stage sectors. |
| Momentum investor | Strong fit while signal remains positive | Momentum fit is conditional on a positive Upturn signal reflecting favorable near-term technical breakouts or earnings beats. |
| Value investor | Strong fit | The stock often trades at reasonable valuation multiples relative to its stable cash flows and essential market position. |
| Dividend investor | Weak fit | Henry Schein historically reinvests earnings into growth rather than paying regular cash dividends. |
| Low-risk investor | Strong fit | As an essential healthcare distributor, the company benefits from defensive demand characteristics and relatively stable cash flows. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | Stock prices experience moderate fluctuations tied to broader healthcare sector sentiment and quarterly earnings reports. |
| Valuation risk | Low | Reasonable trading multiples mitigate severe downside valuation compression risk. |
| Competition risk (alternative distributors and direct manufacturers) | Medium / high | Intense market rivalry from competitors like Patterson, Benco, and major medical suppliers can pressure margins. |
| Business quality | Strong | The company's entrenched market position and indispensable distribution infrastructure underpin solid business quality. |
| Dividend income | Low / none | Income-focused investors will find little direct dividend return as capital is reinvested. |
| Execution risk | Medium | Successful integration of acquisitions and realization of margin-expansion targets are critical for meeting financial goals. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.37B USD | Price to earnings Ratio 23.23 | 1Y Target Price 96.87 |
Price to earnings Ratio 23.23 | 1Y Target Price 96.87 | ||
Volume (30-day avg) 1.5M shares | Beta 0.86 | 52 Weeks Range 68.70 - 92.18 | Updated Date 11/20/2026 |
52 Weeks Range 68.70 - 92.18 | Updated Date 11/20/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 3.65 |
Sector & Industry Intelligence
Sector
Healthcare
Constructive- Sentiment
- Strong Bullish
- Momentum
- BUY Breadth Improving
- BUY participation
- 55.2%
- Active BUY / eligible
- 53 / 96
- 30-Day BUY Count Change
- +19
- Market state
- Strong Bullish
More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.
Industry
Medical Distribution
- BUY participation
- 100.0%
- Active BUY / eligible
- 2 / 2
- 30-Day BUY Count Change
- 0
Eligible universe: 2 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Rolling Over
The price momentum is slowing down and beginning to turn downward.

Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit -17.12% | Avg. Invested days 43 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Global Distribution and Value-Added Services | Distribution of consumable dental and medical supplies, equipment, and related technical and financial services. | This is the primary revenue engine, providing stable, recurring sales of everyday supplies to healthcare offices. |
| Global Specialty Products | Manufacturing and sales of higher-margin dental implants, biomaterials, and orthodontic products. | A higher-margin growth driver that capitalizes on advanced dental procedures and specialty practitioners. |
| Global Technology | Practice management software, digital imaging systems, and e-services for healthcare clinics. | Provides sticky software subscriptions and digital tools that deeply integrate healthcare practices into Henry Schein's ecosystem. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-03 | When Before Market | Estimate 1.34 | Actual 1.56 |
Profitability
Profit Margin 3.07% | Operating Margin (TTM) 5.78% |
Management Effectiveness
Return on Assets (TTM) 4.39% | Return on Equity (TTM) 9.2% |
Valuation
Trailing PE 23.23 | Forward PE 14.22 | Enterprise Value 13.18B | Price to Sales(TTM) 0.68 |
Enterprise Value 13.18B | Price to Sales(TTM) 0.68 | ||
Enterprise Value to Revenue 0.96 | Enterprise Value to EBITDA 12.6 | Shares Outstanding 110.54M | Shares Floating 90.79M |
Shares Outstanding 110.54M | Shares Floating 90.79M | ||
Percent Insiders 0.85 | Percent Institutions 111.22 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

